Yingyao Zhou
Yingyao Zhou has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Bin Zhou
Biologics Research Center, Novartis Biomedical Research , San Diego, CA 92121
3 shared publications- Christopher Benner
Department of Medicine, Division of Endocrinology & Metabolism, University of California, San Diego, La Jolla, California 92093, USA
2 shared publications - Hao Chen
Ray and Stephanie Lane Computational Biology Department, School of Computer Science, Carnegie Mellon University, Pittsburgh, PA 15213, USA; Department of Computer Science, University of Illinois Chicago, Chicago, IL 60607, USA
2 shared publications Joel Hayashi
Novartis Biomedical Research, San Diego, USA
2 shared publicationsJohn Joslin
Novartis Biomedical Research, San Diego, USA
2 shared publications- Lars Pache
Center for Therapeutics Discovery, NCI Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA
2 shared publications
Latest Publications
- Open Access
- 5 November 2024
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 40 (12)
Afpdb: an efficient structure manipulation package for AI protein design
The advent of AlphaFold and other protein Artificial Intelligence (AI) models has transformed protein design, necessitating efficient handling of large-scale data and complex workflows. Using existing programming packages that predate recent AI advancements often leads to inefficiencies in human coding and slow code execution. To address this gap, we developed the Afpdb package. Afpdb, built on AlphaFold’s NumPy architecture, offers a high-performance core. It uses RFDiffusion's contig syntax to streamline residue and atom selection, making coding simpler and more readable. Integrating PyMOL’s visualization capabilities, Afpdb allows automatic visual quality control. With over 180 methods commonly used in protein AI design, which are otherwise hard to find, Afpdb enhances productivity in structural biology by supporting the development of concise, high-performance code. Code and documentation are available on GitHub (https://github.com/data2code/afpdb) and PyPI (https://pypi.org/project/afpdb). An interactive tutorial is accessible through Google Colab. Supplementary data are available at Bioinformatics online.
- 5 November 2024
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 40 (12)
Open AccessAfpdb: an efficient structure manipulation package for AI protein design
The advent of AlphaFold and other protein Artificial Intelligence (AI) models has transformed protein design, necessitating efficient handling of large-scale data and complex workflows. Using existing programming packages that predate recent AI advancements often leads to inefficiencies in human coding and slow code execution. To address this gap, we developed the Afpdb package. Afpdb, built on AlphaFold’s NumPy architecture, offers a high-performance core. It uses RFDiffusion's contig syntax to streamline residue and atom selection, making coding simpler and more readable. Integrating PyMOL’s visualization capabilities, Afpdb allows automatic visual quality control. With over 180 methods commonly used in protein AI design, which are otherwise hard to find, Afpdb enhances productivity in structural biology by supporting the development of concise, high-performance code. Code and documentation are available on GitHub (https://github.com/data2code/afpdb) and PyPI (https://pypi.org/project/afpdb). An interactive tutorial is accessible through Google Colab. Supplementary data are available at Bioinformatics online.
- Top Cited PapersOpen Access
- 29 February 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-15
Drug target prediction through deep learning functional representation of gene signatures
Many machine learning applications in bioinformatics currently rely on matching gene identities when analyzing input gene signatures and fail to take advantage of preexisting knowledge about gene functions. To further enable comparative analysis of OMICS datasets, including target deconvolution and mechanism of action studies, we develop an approach that represents gene signatures projected onto their biological functions, instead of their identities, similar to how the word2vec technique works in natural language processing. We develop the Functional Representation of Gene Signatures (FRoGS) approach by training a deep learning model and demonstrate that its application to the Broad Institute’s L1000 datasets results in more effective compound-target predictions than models based on gene identities alone. By integrating additional pharmacological activity data sources, FRoGS significantly increases the number of high-quality compound-target predictions relative to existing approaches, many of which are supported by in silico and/or experimental evidence. These results underscore the general utility of FRoGS in machine learning-based bioinformatics applications. Prediction networks pre-equipped with the knowledge of gene functions may help uncover new relationships among gene signatures acquired by large-scale OMICs studies on compounds, cell types, disease models, and patient cohorts.
- 29 February 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-15
Top Cited PapersOpen AccessDrug target prediction through deep learning functional representation of gene signatures
Many machine learning applications in bioinformatics currently rely on matching gene identities when analyzing input gene signatures and fail to take advantage of preexisting knowledge about gene functions. To further enable comparative analysis of OMICS datasets, including target deconvolution and mechanism of action studies, we develop an approach that represents gene signatures projected onto their biological functions, instead of their identities, similar to how the word2vec technique works in natural language processing. We develop the Functional Representation of Gene Signatures (FRoGS) approach by training a deep learning model and demonstrate that its application to the Broad Institute’s L1000 datasets results in more effective compound-target predictions than models based on gene identities alone. By integrating additional pharmacological activity data sources, FRoGS significantly increases the number of high-quality compound-target predictions relative to existing approaches, many of which are supported by in silico and/or experimental evidence. These results underscore the general utility of FRoGS in machine learning-based bioinformatics applications. Prediction networks pre-equipped with the knowledge of gene functions may help uncover new relationships among gene signatures acquired by large-scale OMICs studies on compounds, cell types, disease models, and patient cohorts.
- Open Access
- 28 September 2023
- Published by Springer Nature in Research Square
Drug target prediction through deep learning functional representation of gene signatures
Many machine learning applications in bioinformatics currently rely on gene identities extracted from input gene signatures, and fail to take advantage of preexisting knowledge about gene functions. We developed the Functional Representation of Gene Signatures (FRoGS) approach by training a deep learning model. FRoGS represents gene signatures projected onto their biological functions, instead of their identities, similar to how the word2vec technique works in natural language processing. We demonstrated that its application to L1000 datasets resulted in more effective compound-target predictions than models based on gene identities alone. Through further integration of additional pharmacological activity data sources, FRoGS significantly contributed to a large number of high-quality compound-target predictions, which were supported by in silico and/or experimental evidence. These results underscore the general utility of FRoGS in machine learning-based bioinformatics applications. Prediction networks pre-equipped with the knowledge of gene functions may help more readily uncover relationships among gene signatures acquired by large-scale OMICs studies on compounds, cell types, disease models, and patient cohorts.
- 28 September 2023
- Published by Springer Nature in Research Square
Open AccessDrug target prediction through deep learning functional representation of gene signatures
Many machine learning applications in bioinformatics currently rely on gene identities extracted from input gene signatures, and fail to take advantage of preexisting knowledge about gene functions. We developed the Functional Representation of Gene Signatures (FRoGS) approach by training a deep learning model. FRoGS represents gene signatures projected onto their biological functions, instead of their identities, similar to how the word2vec technique works in natural language processing. We demonstrated that its application to L1000 datasets resulted in more effective compound-target predictions than models based on gene identities alone. Through further integration of additional pharmacological activity data sources, FRoGS significantly contributed to a large number of high-quality compound-target predictions, which were supported by in silico and/or experimental evidence. These results underscore the general utility of FRoGS in machine learning-based bioinformatics applications. Prediction networks pre-equipped with the knowledge of gene functions may help more readily uncover relationships among gene signatures acquired by large-scale OMICs studies on compounds, cell types, disease models, and patient cohorts.